BioPharma Dive July 3, 2023
Sponsored content By iliomad Health Data

U.S. life sciences companies that conduct trials in Europe must deal with more than language nuances and time-zone differences. They must also comply with the General Data Protection Regulation (GDPR). This bedrock privacy regulation controls the use of all personal data, not just health data, of persons residing in the EU and the UK. And thanks to its extraterritorial scope, it applies to U.S. trial sponsors, even if they don’t have offices in the EU and the UK.

In this article, we’ll discuss what the GDPR is and why it matters to your life sciences company. We’ll also show you how iliomad Health Data can help you maintain GDPR compliance.

A Brief Overview of the GDPR

The EU adopted the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Clinical Trials, Govt Agencies, Healthcare System, Pharma, Pharma / Biotech, Privacy / Security, Regulations, Trends
Inovalon introduces AI-powered platform to expedite clinical trial recruitment
Will Pharma Continue Efforts to Diversify Clinical Trials?
Substantial portion of cancer patients in early trials access drugs that are later approved, study finds
H1 Welcomes Former FDA Commissioner to Board of Directors, Acquires Ribbon Health, and Unveils 2025 Product Roadmap
mRNA Vaccine Shows Promise In Pancreatic Cancer Trial

Share This Article